CorMedix Inc.
Prices may be delayed up to 15 min. Not investment advice. News volume: articles in the 4Search index each day.
Key statistics
Against its peers
Compare in full ›| CRMD | NVCT | LXRX | SLDB | RLMD | MNKD | |
|---|---|---|---|---|---|---|
| Market cap | 581.46M | 642.76M | 734.18M | 719.48M | 374.41M | 1.01B |
| P/E (TTM) | 3.7 | — | — | — | — | — |
| Forward P/E | 21.3 | -20.5 | -8.7 | -3.9 | -8.6 | 24.5 |
| Price/book | 1.3 | 57.9 | 4.2 | 1.9 | 1.8 | -14.4 |
| Dividend yield | — | — | — | — | — | — |
| 1-year change | −29.22% | +226.53% | +13.01% | +7.70% | +81.87% | −38.63% |
| Today | +1.08% | −6.77% | −1.79% | −2.33% | +3.54% | −4.86% |
The closest companies by business and industry (Biotechnology). Prices may be delayed up to 15 min.
Latest news
All CRMD news ›Head-To-Head Survey: Inhibikase Therapeutics (NASDAQ:IKT) versus CorMedix (NASDAQ:CRMD)
Posted by Tristan Rich on Oct 10th, 2026 CorMedix (NASDAQ:CRMD – Get Free Report) and Inhibikase Therapeutics (NASDAQ:IKT – Get Free Report) are both small-cap healthcare companies, but which is the superior business? We will contrast the…
CorMedix Inc (NASDAQ:CRMD) Stock Has Consensus Price Target of $15.00 According to Analysts
Shares of CorMedix Inc (NASDAQ:CRMD – Get Free Report) have been given an average recommendation of “Moderate Buy” by the nine research firms that are currently covering the stock, Marketbeat.com reports. Two equities research analysts…
CorMedix Inc (NASDAQ:CRMD) Stock Now Rated "Moderate Buy" by Wall Street Analysts
Check Out Our Latest Report on CRMD DefenCath was approved by the U.S. Before you consider CorMedix, you'll want to hear this. While CorMedix currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks…
Financial Comparison: GSK (NYSE:GSK) versus CorMedix (NASDAQ:CRMD)
Posted by Kim Johansen on Oct 1st, 2026 GSK (NYSE:GSK – Get Free Report) and CorMedix (NASDAQ:CRMD – Get Free Report) are both healthcare companies, but which is the superior investment? We will compare the two companies based on the…
ETFs Investing in CorMedix Inc. Stocks — TradingView
CorMedix, Inc. is a pharmaceutical and medical device company, which engages in the development and commercialization of therapeutic products for the prevention and treatment of diseases and conditions. The company was founded by Antony E.…
From articles in the 4Search news index.
In the news
Mentioned with
People in the coverage
Themes
Most coverage from
-
themarketsdaily.com3
-
marketbeat.com1
-
tradingview.com1
Finance and business coverage in the 4Conservative news index: articles that name it in the headline, or in the text beside its ticker. Sentiment is the index's own reading of the latest 5 articles, not a forecast.